![Lymphoma / Histone deacetylase inhibitor / Cutaneous T-cell lymphoma / Romidepsin / Vorinostat / Histone deacetylase / Merck & Co. / Mesothelioma / Targeted therapy / Medicine / Pharmacology / Orphan drugs Lymphoma / Histone deacetylase inhibitor / Cutaneous T-cell lymphoma / Romidepsin / Vorinostat / Histone deacetylase / Merck & Co. / Mesothelioma / Targeted therapy / Medicine / Pharmacology / Orphan drugs](https://www.pdfsearch.io/img/a6a8f64697a52c95a4ffadd339b2c29e.jpg)
| Document Date: 2010-10-19 13:01:20 Open Document File Size: 39,24 KBShare Result on Facebook
Company Merck & Co / Mesothelioma Articles Merck & Co / Genentech / / Event FDA Phase / / IndustryTerm pharmaceutical / / MedicalCondition cancers / cutaneous T-cell lymphoma patients / non-Hodgkin's lymphoma / cutaneous T-cell lymphoma / mesothelioma / cancer / recurrent disease / / MedicalTreatment chemotherapy / / Organization FDA / / Person Benjamin Friedmann / / Product Zolinza / Avastin / Tarceva / / Technology chemotherapy / / URL http /
SocialTag |